Konstantina Thomopoulou MEDICAL ONCOLOGY 5th Medical Oncology Department

• 4/2020-present: Assistant, 1^st Medical Oncology Department, HYGEIA Hospital, Athens, Greece
• 1/2017-3/2020: Residency in Medical oncology with medical on-call duties, University Hospital of Heraklion, Greece
• 8/2015-8/2016: Specilaty Training 1/2 Trust hematology with medical on-call duties, Broomfield Hospital NHS Mid Essex
• 09/2014-04/2015: Clinical Fellow in Medical Oncology, NHS Beatson Hospital, Glasgow
• 08/2012 – 08/2014: Internal Medicine Unit – General Hospital of Ksanthi, Greece
• 01/2012-05/2012: Post graduate Scholarship in medical capacity, Oncology Unit- Hygeia Hospital, Athens, Greece
• 12/2010-12/2011: Rural Obligatory position(agrotiko), Kalavrita Hospital

Education Experience

• 04/2011: 23th National conference of General Medicine, Kos Greece


Talk presentantion: The side effects of diphosphonates in the oral cavity

Talk presentantion:Pre-symptomatic control of colon cancer: public opinion 

• 17-19/11/2017:9^th seminar of Clinical Oncology –Thesaloniki,Greece

Talk presentation: metastatic breast cancer,brca mutation ,different disease ?

• 23-26/11/2017: Conference of clinical and translational oncology

Case presentation: neoadjuvant treatment on rectal cancer 


• 14-16/11/2018: Conference of clinical and translational oncology, Heraklion, Crete,Greece
• Talk presentation: Case of a patient with BRCA mutant TNBCTalk presentation: 2 cases of metastatic adenocarcinoma with high PDL1 expression
• 23–29/3/2019: 18th ESO-ESMO Masterclass in Clinical Oncology , Lodgut Sober, Germany,presentation of a case report (breast cancer)
• 2nd School of Clinical Immunology, Heraklion, Crete, 2019, presentation to students and clinicians of a case with thymoma that received pembrolizumab.
• 4/7/2020: American Association of Cancer Research in collaboration with European platform for cancer research, Methods in Clinical Research workshop, selected for talk presentation of the research idea: phase I trial of ribociclib –nivolumab-canakimumab, trial design.
• 11/7/2020: Panhellenic Oncology Conference, talk on: Immunotherapy toxicity management, and its continuation in patients with response

Clinical Interest:

• Breast cancer 
• Lung Cancer
• Gynecological Malignancies
• Head&Νeck cancer, Thyroid Cancer
• Gastrointestinal cance

  Research Interest:

• Translation Research
• Breast cancer
• Head&Neck cancer
• Lung Cancer

• National Board Examination in Medical Oncology, Greece (2/2020)
• Best poster presentation. 7/2020, Panhellenic Oncology Congress. E-poster theme: microrna’s regulating immune cell interactions in the prediction of early relapse in breast cancer (1^st author)
• Travel award: 4^th ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers 2019, Milan, Italy
• ESMO-Certification in Medical Oncology, September 2019 (ESMO EXAMINATION)
• Travel award: 18^th ESO-ESMO Masterclass in Clinical Oncology 2019, Berlin, Germany
• Travel award: Esmo Oxford Academy 2018, Oxford, UK
• Hygeia Hospital, Athens, Greece 4 months scholarship for post-graduate studies (02/12-5/12).


1. Chara Papadaki, Konstantina Thomopoulou, George Koronakis et al. MicroRNAs involved in immune response as prognostic markers in early and metastatic breast cancer.Journal of Clinical Oncology 2020 38:15_suppl, e15528-e15528
2. Konstantina T, Konstantinos R, Anastasios K, et al. Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review. Lung Cancer. 2019;135:29-32. doi:10.1016/j.lungcan.2019.06.015
3. K Thomopoulou, M Tzardi, D Mavroudis, J Souglakos, A case presentation of a patient with microsatellite instability and BRAF mutant metastatic colon cancer and bibliography update, Case reports in Oncological Medicine ,2019, Article ID 4767019, 5 pageshttps://doi.org/10.1155/2019/4767019
4. Konstantina Thomopoulou, Chara Papadaki, Alexia Monastirioti et al. microRNAs regulating tumor and immune cell interactions in the prediction of early relapse in breast cancer [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P1-05-07.
5. Konstantina Thomopoulou, Stavroula Manolakou, Ippokratis Messaritakis, Maria Tzardi, Eleni Lagoudaki³, Anastasios Koutsopoulos, Andreas Koulouris, George Kanellis, Konstantinos Kalbakis, Dimitris Mavroudis, Ioannis Souglakos, Brain and bone metastases from rectal cancer, Ann Gastroenterol, 2020 Jan-Feb;33(1):95-97. doi: 10.20524/aog.2019.0423. Epub 2019 Oct 8.
6. Maria A Papadaki, Anastasios V Koutsopoulos, Eleni Lagoudaki, Alexia Monastirioti, Konstantina Thomopoulou et al. Comparative analysis of PD-L1 expression on matched primary tumors, metastasis and peripheral blood of patients with breast cancer [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P3-05-03.
7. Stylianos Zervakis, Nikolaos Spernovasilis, Erasmia Boutakoglou, Simeon Panagiotakis, Konstantina Thomopoulou, George Samonis, Erythroderma as a paraneoplastic manifestation of small cell lung cancer, Current problems in Cancer,2019, 100499 https://doi.org/10.1016/j.currproblcancer.2019.
8. Sofia Agelaki, Maria A. Papadaki, Panormitis G Tsoulfas, Despoina Aggouraki, Alexia A Monastirioti, Katerina A Merodoulaki, Konstantina Thomopoulou,Chara Papadaki, Dimitrios Mavroudis, Role of the expression of PD-L1 and CD47 on circulating tumor cells (CTCs) in the prediction of outcome in metastatic breast cancer (mBC) patients. Journal of Clinical Oncology, 37, no. 15_suppl,DOI: 10.1200/JCO.2019.37.15_suppl.e14045
9. Vassias A., Gkiozos I., Thomopoulou K., et al. Effects of Smoking Cessation on lung cancer chemotherapy. Tobacco Prevention & Cessation. 2017;3(May Supplement):63. doi:10.18332/tpc/70836.